Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret G Hines

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|April 17, 2023
Human Antibody V<sub>H</sub> Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for CancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Frontiers in Oncology|October 25, 2023
Human antibody V<sub>H</sub> domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Frontiers in Immunology|February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancersXiaojie Chu, Du-San Baek, Wei Li, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Science Advances|February 4, 2026
Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptorSeungmin Shin, Yae-Jin Kim, Bernard J C Macatangay, et al.
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|April 17, 2023
Human Antibody V<sub>H</sub> Domains Targeting GPNMB and VCAM-1 as Candidate Therapeutics for CancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Frontiers in Oncology|October 25, 2023
Human antibody V<sub>H</sub> domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
Frontiers in Immunology|February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancersXiaojie Chu, Du-San Baek, Wei Li, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Science Advances|February 4, 2026
Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptorSeungmin Shin, Yae-Jin Kim, Bernard J C Macatangay, et al.
Nature Communications|August 20, 2024
CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastomaGuillem Pascual-Pasto, Brendan McIntyre, Margaret G Hines, et al.
Pageof 1